The $3,000 Dog Vaccine That Big Pharma Craves - Energy & Capital
Takeda just dropped $1.7 billion on a deal with Iambic Therapeutics a month ago, and Merck developed something called KERMT, which is an AI model that ...
Energy & Capital 1
Covers: Energy & EnvironmentHealthcare